Matthieu Prot

This study shows human coronavirus HKU1 replicates more efficiently at nasal temperature (33°C) than at body temperature (37°C), with differences in innate immune response and viral stability.

The paper identifies novel SARS-CoV-2-related viruses in Cambodian bats, revealing genetic diversity and potential zoonotic risk through receptor-binding domain analysis and pseudovirus assays.

This study shows that a non-retroviral EVE suppresses viral replication in mosquitoes across life stages and generations but does not affect survival or reproduction.

The paper identifies polygenic viral factors in African Zika virus strains that enhance mosquito transmission efficiency compared to Asian strains.

This paper modifies a measles vaccine by removing a viral protein to create a cancer immunotherapy that activates the immune system via RIG-I signaling, leading to tumor regression in multiple models.

The paper evaluates the neutralization activity of two new monoclonal antibodies against emerging SARS-CoV-2 variants and finds reduced efficacy against some sublineages.

This study characterizes SARS-CoV-2 variants XBB and BA.2.86/JN.1, finding they show increased fitness and antibody evasion while maintaining antiviral sensitivity.

This study characterizes the high fusogenicity and cytopathic effects of the SARS-CoV-2 B.1.640.1 variant, identifying mutations in the spike S2 domain responsible for these properties.

This study shows that genetic diversity in Collaborative Cross mice affects ZIKV infection outcomes, including viral replication and disease severity, independent of Oas1b.